Your browser doesn't support javascript.
loading
Overriding Adaptive Resistance to Sorafenib Through Combination Therapy With Src Homology 2 Domain-Containing Phosphatase 2 Blockade in Hepatocellular Carcinoma.
Leung, Carmen Oi Ning; Tong, Man; Chung, Katherine Po Sin; Zhou, Lena; Che, Noélia; Tang, Kwan Ho; Ding, Jin; Lau, Eunice Yuen Ting; Ng, Irene Oi Lin; Ma, Stephanie; Lee, Terence Kin Wah.
  • Leung CON; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong.
  • Tong M; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.
  • Chung KPS; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong.
  • Zhou L; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.
  • Che N; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.
  • Tang KH; Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, NYU Langone Health, New York, NY.
  • Ding J; The International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
  • Lau EYT; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong.
  • Ng IOL; Department of Pathology, The University of Hong Kong, Hong Kong.
  • Ma S; State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong.
  • Lee TKW; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.
Hepatology ; 72(1): 155-168, 2020 07.
Article en En | MEDLINE | ID: mdl-31610028

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piperidinas / Pirimidinas / Carcinoma Hepatocelular / Resistencia a Antineoplásicos / Proteínas Tirosina Fosfatasas con Dominio SH2 / Sorafenib / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piperidinas / Pirimidinas / Carcinoma Hepatocelular / Resistencia a Antineoplásicos / Proteínas Tirosina Fosfatasas con Dominio SH2 / Sorafenib / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article